Han S, Chen Z J, Zhou D, Zheng P, Zhang J H, Jia G
Department of Occupational and Environmental Health Sciences, Peking University School of Public Health, Beijing 100191, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Jun 18;52(3):457-463. doi: 10.19723/j.issn.1671-167X.2020.03.010.
To explore the effects and related mechanisms of oral exposure titanium dioxide nanoparticles (TiO NPs) for 90 days on the intestinal and the gut microbiota of rats, through fecal metabolomics.
Twelve 4-week-old clean-grade Sprague Dawley (SD) rats were randomly de-vided into 2 groups by body weight, treated with TiO NPs at dose of 0 or 50 mg/kg body weight everyday respectively for 90 days. The solution of each infection was freshly prepared and shocked fully by ultrasonic. Characterization of the particle size, crystal form, purity, and specific surface area of TiO NPs was conducted. And the fresh feces of the rats were collected on the 90th day. After lyophilized and hydrophilic phase extraction, ultra performance liquid chromatography-Q-exactive orbitrap-high-resolution mass spectrometry system (UPLC-QEMS) was utilized for non-targeted determination of fecal meta-bolites. The metabolites were identified and labeled through Compound Discoverer 3.0 software, and used for subsequent metabolomics analysis. Bioinformatics analysis was carried out including unsupervised principal component analysis and supervised orthogonal projection to latent structure discriminant analysis for the differential metabolites between the two groups. The differential metabolites were followed-up for Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
Compared with the control group, the body weight of the rats was significantly reduced (<0.05) in the treatment group. A total of 22 metabolites in fecal metabolomics showed significant changes. Among them, xanthine, 1-methyladenine, 3-hydroxypyridine, methionine sulfoxide, pyridoxine, 1,5-isoquinolinediol, N-acetylornithine, N-acetyl-D-galactosamine, L-citrulline, L-methionine, leucine, DL-tryptophan, L-ornithine, 4-methyl-5-thiazoleethanol, and L-glutamic acid totaled 15 metabolites increased significantly. N-acetylhistamine, D-pipecolinic acid, imidazolelactic acid, L-valine, 2,3,4,6-tetramethylpyrazine, caprolactam, and histamine totaled 7 metabolites decreased significantly. N-acetylhistamine, L-valine and methionine sulfoxide were changed more than 16 times. Analysis of KEGG pathway revealed that the two metabolic pathways arginine biosynthesis and aminoacyl-tRNA biosynthesis were significantly changed (false discover rate < 0.05, pathway impact > 0.1).
Oral exposure to TiO NPs for 90 days could disrupt the metabolism of the intestine and gut microbiota, causing significant changes in metabolites and metabolic pathways which were related to inflammatory response, oxidative stress, glucose homeostasis, blood system and amino acid homeostasis in rat feces. It is suggested that the toxic effect of TiO NPs on rats may be closely related to intestinal and gut microbiota metabolism.
通过粪便代谢组学研究大鼠经口暴露二氧化钛纳米颗粒(TiO NPs)90天对肠道及肠道微生物群的影响及其相关机制。
将12只4周龄清洁级Sprague Dawley(SD)大鼠按体重随机分为2组,分别以0或50 mg/kg体重的剂量每日给予TiO NPs处理90天。每种染毒溶液均新鲜配制并经超声充分震荡。对TiO NPs进行粒径、晶型、纯度及比表面积表征。在第90天收集大鼠新鲜粪便。经冻干及亲水相萃取后,采用超高效液相色谱-Q-Exactive轨道阱高分辨质谱系统(UPLC-QEMS)对粪便代谢物进行非靶向测定。通过Compound Discoverer 3.0软件对代谢物进行鉴定和标注,并用于后续代谢组学分析。对两组间差异代谢物进行生物信息学分析,包括无监督主成分分析和有监督的正交投影到潜在结构判别分析。对差异代谢物进行京都基因与基因组百科全书(KEGG)通路分析。
与对照组相比,处理组大鼠体重显著降低(<0.05)。粪便代谢组学共显示22种代谢物有显著变化。其中,黄嘌呤、1-甲基腺嘌呤、3-羟基吡啶、甲硫氨酸亚砜、吡哆醇、1,5-异喹啉二醇、N-乙酰鸟氨酸、N-乙酰-D-半乳糖胺、L-瓜氨酸、L-甲硫氨酸、亮氨酸、DL-色氨酸、L-鸟氨酸、4-甲基-5-噻唑乙醇和L-谷氨酸共15种代谢物显著增加。N-乙酰组胺、D-哌啶酸、咪唑乳酸、L-缬氨酸、2,3,4,6-四甲基吡嗪、己内酰胺和组胺共7种代谢物显著减少。N-乙酰组胺、L-缬氨酸和甲硫氨酸亚砜变化超过16倍。KEGG通路分析显示,精氨酸生物合成和氨酰-tRNA生物合成两条代谢通路显著改变(错误发现率<0.05,通路影响>0.1)。
大鼠经口暴露TiO NPs 90天可扰乱肠道及肠道微生物群的代谢,导致与大鼠粪便中炎症反应、氧化应激、葡萄糖稳态、血液系统及氨基酸稳态相关的代谢物及代谢通路发生显著变化。提示TiO NPs对大鼠的毒性作用可能与肠道及肠道微生物群代谢密切相关。